WallStreetZenWallStreetZen

NYSE: ABBV
Abbvie Inc Stock Forecast, Predictions & Price Target

Analyst price target for ABBV

Based on 6 analysts offering 12 month price targets for Abbvie Inc.
Min Forecast
$150.00+5.34%
Avg Forecast
$171.67+20.56%
Max Forecast
$196.00+37.65%

Should I buy or sell ABBV stock?

Based on 6 analysts offering ratings for Abbvie Inc.
Strong Buy
Strong Buy
4 analysts 66.67%
Buy
1 analysts 16.67%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ABBV stock forecasts and price targets.

ABBV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-01
lockedlocked$00.00+00.00%2023-11-09
lockedlocked$00.00+00.00%2023-10-30
lockedlocked$00.00+00.00%2023-10-30Find Out Why
lockedlocked$00.00+00.00%2023-07-28Find Out Why
HSBC
Top 34%
67
Strong BuyInitiates Coverage On$167.00+17.28%2023-07-14

1 of 1

Forecast return on equity

Is ABBV forecast to generate an efficient return?
Company
N/A
Industry
13.55%
Market
30.08%

Forecast return on assets

Is ABBV forecast to generate an efficient return on assets?
Company
N/A
Industry
5.57%

ABBV revenue forecast

What is ABBV's revenue in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$54.1B-1.96%
Avg 2 year Forecast
$53.9B-2.25%
Avg 3 year Forecast
$57.5B+4.3%
ABBV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ABBV earnings growth forecast

How is ABBV forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
50.77%
Industry
32.44%
Market
17.67%
ABBV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ABBV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ABBV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ABBV revenue growth forecast

How is ABBV forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
1.01%
Industry
4.25%
Market
7.51%
ABBV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ABBV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ABBV vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
ABBV$142.39$171.67+20.56%Strong Buy
MRK$102.48$124.17+21.16%Buy
NVS$97.90N/AN/A
AZN$64.59$81.50+26.18%Strong Buy
PFE$30.47$40.67+33.47%Buy

Abbvie Stock Forecast FAQ

Is Abbvie Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock.

Out of 6 analysts, 4 (66.67%) are recommending ABBV as a Strong Buy, 1 (16.67%) are recommending ABBV as a Buy, 1 (16.67%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are recommending ABBV as a Strong Sell.

If you're new to stock investing, here's how to buy Abbvie stock.

What is ABBV's revenue growth forecast for 2023-2025?

(NYSE: ABBV) Abbvie's forecast annual revenue growth rate of 1.01% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 4.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.51%.

Abbvie's revenue in 2023 is $55,138,000,000.On average, 9 Wall Street analysts forecast ABBV's revenue for 2023 to be $95,439,845,279,501, with the lowest ABBV revenue forecast at $95,257,625,927,817, and the highest ABBV revenue forecast at $95,989,594,790,577. On average, 9 Wall Street analysts forecast ABBV's revenue for 2024 to be $95,161,997,358,946, with the lowest ABBV revenue forecast at $93,165,644,168,749, and the highest ABBV revenue forecast at $97,193,765,464,271.

In 2025, ABBV is forecast to generate $101,536,556,728,800 in revenue, with the lowest revenue forecast at $96,924,473,338,058 and the highest revenue forecast at $104,587,082,298,940.

What is ABBV's forecast return on assets (ROA) for 2023-2026?

(NYSE: ABBV) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - General industry average of 5.57%.

What is ABBV's Price Target?

According to 6 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $171.67, with the highest ABBV stock price forecast at $196.00 and the lowest ABBV stock price forecast at $150.00.

On average, Wall Street analysts predict that Abbvie's share price could reach $171.67 by Nov 9, 2024. The average Abbvie stock price prediction forecasts a potential upside of 20.56% from the current ABBV share price of $142.39.

What is ABBV's forecast return on equity (ROE) for 2023-2026?

(NYSE: ABBV) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.